PANO THERAPEUTICS, INC. ANNOUNCES THE STRATEGIC ACQUISITION OF NOVATARG THERAPEUTICS, INC. AND THE APPOINTMENT OF KEN BATCHELOR, PHD AS HEAD OF RESEARCH & DEVELOPMENT. Ben GibsonApril 25, 2022
